New Glycine-Modified Growth Hormone Secretagogues Found in Seized Doping Materials
Background
Growth hormone secretagogues (GHSs) are a class of peptides known to stimulate the body's natural production and release of growth hormone. Due to their potential to enhance muscle mass, reduce fat, and improve recovery, GHSs are frequently misused as performance-enhancing substances in sports. The continuous evolution of doping practices, including chemical modifications to known compounds, poses a significant challenge to anti-doping efforts worldwide. This study addresses the critical knowledge gap of identifying novel, chemically modified GHS forms that might currently evade standard detection methods, thereby compromising fair competition.
Results
The LC-HRMS analysis provided clear and unequivocal identification of the contents of the seized powders. The substances were confirmed to be analogs of several well-known growth hormone secretagogues, specifically GHRP-2 (Pralmorelin), GHRP-6, Ipamorelin, and modified growth hormone releasing factor (modified GRF 1-29). The most crucial discovery was that, in all cases, the identified GHS analogs shared a specific, novel chemical modification: the addition of an extra glycine amino acid at their N-terminus (the beginning of the peptide chain). This consistent N-terminal glycine modification across multiple GHS types suggests a deliberate strategy to alter these compounds, potentially to modify their pharmacological properties or evade detection. The identification was robustly confirmed through direct comparison with established reference standards.
Why It Matters
This groundbreaking discovery represents a significant new challenge for global anti-doping agencies and laboratories, as these glycine-modified GHSs are unlikely to be detected by current, standard screening protocols. The identification of these novel modified peptides necessitates an immediate and comprehensive update to existing analytical methods and reference standards used for detecting growth hormone secretagogues. Developing and implementing new detection strategies for these modified compounds is paramount to maintaining the integrity of sports and ensuring effective substance abuse detection in athletes. This research provides critical intelligence, directly informing the next steps for anti-doping organizations worldwide to adapt their screening programs and close this emerging loophole.